scholarly journals Life-saving veno venous extracorporeal membrane oxygenation (VV-ECMO) in a case of potentially fatal massive hemoptysis due to bronchiectasis: a case report

2016 ◽  
Vol 23 (3) ◽  
pp. 324-327
Author(s):  
Mitsuhiro Suzuki ◽  
Taisuke Yokota ◽  
Sayaka Gomei ◽  
Tatsuhiko Saiki ◽  
Toshirou Kamisasanuki ◽  
...  
Keyword(s):  
Case Report ◽  
Extracorporeal Membrane Oxygenation ◽  
Massive Hemoptysis ◽  
Membrane Oxygenation ◽  
Life Saving ◽  
Vv Ecmo

Hybrid extracorporeal membrane oxygenation (ECMO) cannulation following traumatic pneumonectomy: A case report

Trauma ◽  
2022 ◽  
pp. 146040862110552
Author(s):  
Jay I Conhaim ◽  
Nick C Levinsky ◽  
Paige L Barger ◽  
Heather L Palomino
Keyword(s):  
Heart Failure ◽  
Case Report ◽  
Extracorporeal Membrane Oxygenation ◽  
Right Heart Failure ◽  
Flow Limitation ◽  
Right Heart ◽  
Membrane Oxygenation ◽  
Operative Complications ◽  
Potential Loss ◽  
Vv Ecmo

A 28-year-old man presented in extremis after a motorcycle crash. Following traumatic pneumonectomy, he developed right heart failure and was placed on veno-arterial (VA) extracorporeal membrane oxygenation (ECMO) only to transition to veno-arteriovenous (VAV) ECMO due to persistent hypoxemia. Resulting flow limitation caused distal ischemia of his left leg, requiring thrombectomy and fasciotomy. Potential loss of limb necessitated transitioning to veno-venous (VV) ECMO from which he was successfully decannulated thereafter. ECMO can bridge recovery following the most dire injuries, and hybrid strategies can ameliorate post-operative complications; however, ECMO itself carries significant risks that must be weighed against intended benefit.

scholarly journals The use of veno‐venous extracorporeal membrane oxygenation for massive hemoptysis following a traumatic lung injury: a case report

2020 ◽  
Vol 7 (1) ◽  
Author(s):  
Takuya Sugiyama ◽  
Tokiya Ishida ◽  
Hideyuki Yokoyama ◽  
Yoshibumi Kumada ◽  
Kazuaki Shinohara
Keyword(s):  
Case Report ◽  
Lung Injury ◽  
Extracorporeal Membrane Oxygenation ◽  
Massive Hemoptysis ◽  
Membrane Oxygenation

scholarly journals Suspected Heparin-Induced Thrombocytopenia in a COVID-19 Patient on Extracorporeal Membrane Oxygenation Support: A Case Report.

2020 ◽  
Author(s):  
Xuan T. Phan ◽  
Tuan Huu Nguyen ◽  
Tung T. Tran ◽  
Thu-Hien T. Huynh ◽  
Thuy-Ha T. Hoang ◽  
...  
Keyword(s):  
Case Report ◽  
Adverse Events ◽  
Extracorporeal Membrane Oxygenation ◽  
Ecmo Support ◽  
Specific Situation ◽  
Heparin Induced Thrombocytopenia ◽  
Case Presentation ◽  
Membrane Oxygenation ◽  
Life Saving ◽  
Number Of Patients

Abstract Background: Extracorporeal membrane oxygenation (ECMO) support can be life-saving in critically ill COVID-19 patients. However, there are many complications associated with this procedure, including Heparin-induced thrombocytopenia (HIT.) Despite its rarity in ECMO cases, HIT can lead to devastating consequences and is difficult to manage. Case presentation: In this report, we present a case of a COVID-19 patient on ECMO support who was diagnosed with HIT and required intensive treatment. Initially, HIT was only suspected due to newly-developed thrombocytopenia and oxygenator dysfunction, with thrombi observed later. Regarding his treatment, since there was no recommended replacement to heparin available to us at the time of diagnosis, we decided to use rivaroxaban temporarily. No adverse events were recorded during that period. The patient was able to make a full recovery.Conclusion: HIT may jeopardize patient’s care during ECMO. As COVID-19 may bring about a surge in the number of patients requiring ECMO support, we need consented guidance to optimize treatment in this specific situation.

scholarly journals Suspected Heparin-Induced Thrombocytopenia in a COVID-19 Patient on Extracorporeal Membrane Oxygenation Support: A Case Report.

2020 ◽  
Author(s):  
Xuan T. Phan ◽  
Tuan Huu Nguyen ◽  
Tung T. Tran ◽  
Thu-Hien T. Huynh ◽  
Thuy-Ha T. Hoang ◽  
...  
Keyword(s):  
Case Report ◽  
Adverse Events ◽  
Extracorporeal Membrane Oxygenation ◽  
Ecmo Support ◽  
Specific Situation ◽  
Heparin Induced Thrombocytopenia ◽  
Case Presentation ◽  
Membrane Oxygenation ◽  
Life Saving ◽  
Number Of Patients

Abstract Background: Extracorporeal membrane oxygenation (ECMO) support can be life-saving in critically ill COVID-19 patients. However, there are many complications associated with this procedure, including Heparin-induced thrombocytopenia (HIT.) Despite its rarity in ECMO cases, HIT can lead to devastating consequences and is difficult to manage. Case presentation: In this report, we present a case of a COVID-19 patient on ECMO support who was diagnosed with HIT and required intensive treatment. Initially, HIT was only suspected due to newly-developed thrombocytopenia and oxygenator dysfunction, with thrombi observed later. Regarding his treatment, since there was no recommended replacement to heparin available to us at the time of diagnosis, we decided to use rivaroxaban temporarily. No adverse events were recorded during that period. The patient was able to make a full recovery. Conclusion: HIT may jeopardize patient’s care during ECMO. As COVID-19 may bring about a surge in the number of patients requiring ECMO support, we need consented guidance to optimize treatment in this specific situation.

scholarly journals Suspected heparin-induced thrombocytopenia in a COVID-19 patient on extracorporeal membrane oxygenation support: a case report

2020 ◽  
Vol 18 (1) ◽  
Author(s):  
Xuan T. Phan ◽  
Tuan H. Nguyen ◽  
Tung T. Tran ◽  
Thu-Hien T. Huynh ◽  
Thuy-Ha T. Hoang ◽  
...  
Keyword(s):  
Case Report ◽  
Adverse Events ◽  
Extracorporeal Membrane Oxygenation ◽  
Ecmo Support ◽  
Specific Situation ◽  
Heparin Induced Thrombocytopenia ◽  
Case Presentation ◽  
Membrane Oxygenation ◽  
Life Saving ◽  
Number Of Patients

Abstract Background Extracorporeal membrane oxygenation (ECMO) support can be life-saving in critically ill COVID-19 patients. However, there are many complications associated with this procedure, including Heparin-induced thrombocytopenia (HIT.) Despite its rarity in ECMO cases, HIT can lead to devastating consequences and is difficult to manage. Case presentation In this report, we present a case of a COVID-19 patient on ECMO support who was diagnosed with HIT and required intensive treatment. Initially, HIT was only suspected due to newly-developed thrombocytopenia and oxygenator dysfunction, with thrombi observed later. Regarding his treatment, since there was no recommended replacement to heparin available to us at the time of diagnosis, we decided to use rivaroxaban temporarily. No adverse events were recorded during that period. The patient was able to make a full recovery. Conclusion HIT may jeopardize patient’s care during ECMO. As COVID-19 may bring about a surge in the number of patients requiring ECMO support, we need consented guidance to optimize treatment in this specific situation.

scholarly journals Suspected Heparin-Induced Thrombocytopenia in a COVID-19 Patient on Extracorporeal Membrane Oxygenation Support: A Case Report.

2020 ◽  
Author(s):  
Xuan T. Phan ◽  
Tuan Huu Nguyen ◽  
Tung T. Tran ◽  
Thu-Hien T. Huynh ◽  
Thuy-Ha T. Hoang ◽  
...  
Keyword(s):  
Case Report ◽  
Adverse Events ◽  
Extracorporeal Membrane Oxygenation ◽  
Ecmo Support ◽  
Specific Situation ◽  
Heparin Induced Thrombocytopenia ◽  
Case Presentation ◽  
Membrane Oxygenation ◽  
Life Saving ◽  
Number Of Patients

Abstract Background: Extracorporeal membrane oxygenation (ECMO) support can be life-saving in critically ill COVID-19 patients. However, there are many complications associated with this procedure, including Heparin-induced thrombocytopenia (HIT.) Despite its rarity in ECMO cases, HIT can lead to devastating consequences and is difficult to manage. Case presentation: In this report, we present a case of a COVID-19 patient on ECMO support who was diagnosed with HIT and required intensive treatment. Initially, HIT was only suspected due to newly-developed thrombocytopenia and oxygenator dysfunction, with thrombi observed later. Regarding his treatment, since there was no recommended replacement to heparin available to us at the time of diagnosis, we decided to use rivaroxaban temporarily. No adverse events were recorded during that period. The patient was able to make a full recovery.Conclusion: HIT may jeopardize patient’s care during ECMO. As COVID-19 may bring about a surge in the number of patients requiring ECMO support, we need consented guidance to optimize treatment in this specific situation.

scholarly journals Suspected Heparin-Induced Thrombocytopenia in a COVID-19 Patient on Extracorporeal Membrane Oxygenation Support: A Case Report.

2020 ◽  
Author(s):  
Xuan T. Phan ◽  
Tuan Huu Nguyen ◽  
Tung T. Tran ◽  
Thu-Hien T. Huynh ◽  
Thuy-Ha T. Hoang ◽  
...  
Keyword(s):  
Case Report ◽  
Adverse Events ◽  
Extracorporeal Membrane Oxygenation ◽  
Ecmo Support ◽  
Specific Situation ◽  
Heparin Induced Thrombocytopenia ◽  
Case Presentation ◽  
Membrane Oxygenation ◽  
Life Saving ◽  
Number Of Patients

Abstract Background: Extracorporeal membrane oxygenation (ECMO) support can be life-saving in critically ill COVID-19 patients. However, there are many complications associated with this procedure, including Heparin-induced thrombocytopenia (HIT.) Despite its rarity in ECMO cases, HIT can lead to devastating consequences and is difficult to manage.Case presentation: In this report, we present a case of a COVID-19 patient on ECMO support who was diagnosed with HIT and required intensive treatment. Initially, the patient showed no remarkable sign of thrombosis and HIT was only suspected due to newly-developed thrombocytopenia and oxygenator dysfunction. Regarding his treatment, since there was no recommended replacement to heparin available to us at the time of diagnosis, we decided to use Rivaroxaban temporarily. No adverse events were recorded during that period. The patient was able to make a full recovery.Conclusion: HIT may jeopardize patient’s care during ECMO. As COVID-19 may bring about a surge in the number of patients requiring ECMO support, we need consented guidance to optimize treatment in this specific situation.

scholarly journals Case Report: Prolonged VV-ECMO (111 Days) Support in a Patient With Severe COVID-19

2021 ◽  
Vol 8 ◽  
Author(s):  
Zhiheng Xu ◽  
Yonghao Xu ◽  
Dongdong Liu ◽  
Xuesong Liu ◽  
Liang Zhou ◽  
...  
Keyword(s):  
Case Report ◽  
Mortality Rate ◽  
Extracorporeal Membrane Oxygenation ◽  
Supportive Care ◽  
High Mortality ◽  
Rescue Therapy ◽  
Membrane Oxygenation ◽  
Venovenous Extracorporeal Membrane Oxygenation ◽  
Vv Ecmo

Venovenous extracorporeal membrane oxygenation (VV-ECMO) may be a lifesaving rescue therapy for patients with severe coronavirus disease 2019 (COVID-19). However, little is known regarding the efficacy of prolonged ECMO (duration longer than 14 days) in patients with COVID-19. In this case report, we report the successful use of prolonged VV-ECMO (111 days) in a 61-year-old man with severe COVID-19. Given the high mortality rate of severe COVID-19, this case provided evidence for use of prolonged VV-ECMO as supportive care in patients with severe COVID-19.

Sign in / Sign up

Export Citation Format

Share Document